News Articles Tagged: Restenosis

Zotarolimus: The Powerhouse API Intermediate for Stent Manufacturers

Discover Zotarolimus (CAS 221877-54-9), the key API intermediate enabling advanced drug-eluting stents. Learn about its role in restenosis prevention and why sourcing from a reliable manufacturer is crucial.

The Role of Sirolimus in Advanced Cardiovascular Care: Coronary Stent Coatings

Explore how Sirolimus (Rapamycin) powder is integral to advanced coronary stent technology, preventing restenosis and improving cardiac health. NINGBO INNO PHARMCHEM CO.,LTD. supplies high-quality Sirolimus for this critical application.

Sirolimus in Cardiovascular Health: The Impact of Drug-Eluting Stents

Examines the role of Sirolimus in drug-eluting stents for preventing restenosis and improving outcomes in cardiovascular procedures.

The Dual Role of Rapamycin: From Immunosuppression to Cardiovascular Health

Discover how rapamycin's powerful immunosuppressive properties are harnessed in cardiovascular medicine, particularly in preventing restenosis with sirolimus-eluting stents.